Artemether/Lumefantrine 80/480mg is a fixed-dose artemisinin-based combination therapy (ACT) used for the treatment of uncomplicated Plasmodium falciparum malaria in adults and children weighing 25 kg or more. It is a first-line recommended treatment on the WHO Essential Medicines List and NHIS formulary.
Each pack contains 30 tablets for a complete 3-day course (6 doses). Artemether rapidly reduces parasite load while lumefantrine provides a prolonged effect to eliminate remaining parasites.
- WHO Essential Medicine — recommended first-line ACT
- NHIS Ghana reimbursable — present patient NHIS card at dispensing
- Complete 3-day course in one pack (30 tablets, 6 doses)
- Cold-chain not required — store below 30°C, away from light
- Generic equivalent of Coartem® — same active ingredients and bioequivalence
Scan batch on delivery
Use the BenephaRx app to scan this batch's QR code at receipt. Verifies against FDA Ghana ledger in under 3 seconds. Result is immutably recorded in your audit log.